Aggregated real-time headlines, trending Google search queries, and verified dispatches in one single page.
<a href="https://news.google.com/rss/articles/CBMiXEFVX3lxTE9Gcy1mSXFBUjR0UGszMWF4TS1nRnRrZDYtQmNzS3EzN1N4MXptUTRjbGdvUmVhRTFKR1ZjMll2TUpZZG1STmppempsdWJvSkYzWVRwdmpfY3dUT3Na?oc=5" target="_blank">Engineering chimeric antigen receptor CD4 T cells for Alzheimer’s disease</a>&nbsp;&nbsp;<font color="#6f6f6f">PNAS</font>
Champions League Matchday 2: Key stats and what to look out for in every game
Adult victims, suspected shooter ID'd in Erie mass shooting
Northern Lights Forecast: Aurora Could Be Visible From These 10 States Monday
Selma Blair Arrested, Attacks Flight Crew After Trying to Open Plane Door Mid-Air
Updated every 3 minutes via FreeNewsApi, GNews, Currents API & Google News
<a href="https://news.google.com/rss/articles/CBMiX0FVX3lxTE5GcGRFQk9PM1N2TXZUa2ZTTVFJbENHN2RXeDR1LTY3anJ4bFlITHB2LTFHNUZtaFlGNW0xREFEaU9vNUp3ampFUll6eFdNNm90YXlWSXNGNkJ3aTA1ckc4?oc=5" target="_blank">In vivo site-specific engineering to reprogram T cells</a>&nbsp;&nbsp;<font color="#6f6f6f">Nature</font>
<a href="https://news.google.com/rss/articles/CBMitAFBVV95cUxNR3VES2hlTU9HYjVvdzhtMjVmTWE3UXpHRXN4aUVpMmdpWEJ4Q2RIeHA0R2x1OTNIY1dLSW1ZOHppYnJWWmhOLV9yTHJGWFhyU0g0VkdCazVpdm9wRWVsTEJVZVpyUFlVX2NJY0hNY1kxTlJnZS1laXFFVFdYT3RMMmZmN0dTbDFSeU1tUGlnbmpNR1h0X0dVcmlGeEg2dl96OWR3aExZVEFBNUxsd1VJTTlKbTc?oc=5" target="_blank">Nanoparticles Trigger In Vivo CAR T Cell Generation to Eliminate B Cells</a>&nbsp;&nbsp;<font color="#6f6f6f">Genetic Engineering and Biotechnology News</font>
<a href="https://news.google.com/rss/articles/CBMiX0FVX3lxTFA5bzhpSFhtdFhQbGV4WVg2YnRKZnV2X2FPMmxyVXJpbF96aC1oYk9LNEFVZjZoLUtVZzJZaE5pWm9sNmFjalRVVFZjRHFYOEczY1U5UTc2ZjY1RnVNVjc4?oc=5" target="_blank">Anti-MSLN chimeric antigen receptor-like NK cell therapy with tumor-penetrating capacity (uCAR-like NK) for solid tumors | Signal Transduction and Targeted Therapy</a>&nbsp;&nbsp;<font color="#6f6f6f">Nature</font>
<a href="https://news.google.com/rss/articles/CBMiqgFBVV95cUxPRWUxMUdRc1dqMWc0WmpsR0tXaU1TUEFHN2FPb3Fxc2ktR2c5MUhWWUE1Q2dSOUdkempFR2J1eVZ4RC0xc3l0THhqN0dsRzNtTDhjcndOa1JtRk9oTU5CazdYQlF3NUlZV0pwcjVKeUo5SVB1RVpUV3hNZ3h4VFJJcFVpd0FqcXd4WGJQLXp2OHNNRVMyUl9xS3dnZFZpYUNvaXZJcDZPZHdWQQ?oc=5" target="_blank">Boosted 'Natural Killer' Cells Could Lead to Off-The-Shelf Cancer Immunotherapy</a>&nbsp;&nbsp;<font color="#6f6f6f">ScienceAlert</font>
<a href="https://news.google.com/rss/articles/CBMiYEFVX3lxTFBFYVRCWmpFS1h2aG5iVmVZT05FS1Y1TVNTNlVhWU1WRzNvN3MydmtsR1R6NV9GcjlXb0lGeVBrNUZwd01RWVFXbldVT29OUm5oamp0X1BEMnpJeEN4QVY0Tw?oc=5" target="_blank">Targeting amyloid-β pathology by chimeric antigen receptor astrocyte (CAR-A) therapy</a>&nbsp;&nbsp;<font color="#6f6f6f">Science | AAAS</font>
<a href="https://news.google.com/rss/articles/CBMipgFBVV95cUxQN2lzUUxWX3ZraTRMb0txSUFKcnktS1pKMGMzd1VmanI4ZGhFUFdsTVNrcmg5M01vQ1huekhReVNueFlTa0NCZWZRZGlrQlZlT1dqNTJEa3V6UEJsQkxBQmlrWnRoUm5uNk4yT2xMeXdYeXo1bm9UcFF2QTVWc3U2RzJoQnFVNDMzZG4tbmMwbmJ5U09obThUbmtWX09lLWpCakVlQ0NB?oc=5" target="_blank">Engineering Recombinant Chimeric Proteins That Deliver Therapies to the Brain</a>&nbsp;&nbsp;<font color="#6f6f6f">ACS Publications</font>
<a href="https://news.google.com/rss/articles/CBMiY0FVX3lxTE9rdk1jRWxsQl9GWVJ1ZHJaS2FJdmF2Q0NKZVBUWXdlSkZLWnMzYmxyNGl0RHJxd2Y0VVdEbVlOREhXR01sY0JncU1LS0hRcDRQdGpWb0JUY2MxakVqcndONXJfVQ?oc=5" target="_blank">Engineering chimeric antigen receptor T cells for solid tumour therapy - Liu - 2022 - Clinical and Translational Medicine</a>&nbsp;&nbsp;<font color="#6f6f6f">Wiley Online Library</font>
<a href="https://news.google.com/rss/articles/CBMi0AFBVV95cUxQdXdtT1VPdHI1X0FyYm9yZmQtSXozcGhrZWk2Z21jR01sTWlBSDRxa05IUkpqZlViUG5TQnRxaEJLWlFYMEt2UTZpYlZOc0NaNTFSaE5rakVyaFdodXNtNnJnb2pkX1VIMUcweGlQOUkybVV1QlVSOTJENmZNUS10SEtyc3hlVHhCeFM1c3FyUHJSMWZGMHpkZHliSElyTGxsQTJJM21tYjRudE4tNy1VRkM4REpCRWs2QzhpUmlsVC00a0s5QWU0Qy1BeFRKSEdC?oc=5" target="_blank">Alzheimer’s plaques decline after CAR-T immune cell treatment in preclinical study</a>&nbsp;&nbsp;<font color="#6f6f6f">News-Medical</font>
<a href="https://news.google.com/rss/articles/CBMitgFBVV95cUxPa3VrZUM2TGNEcnNfWUdIbHN0QWNwcXpJWjVrazhNUVVYUzRZZGJfLVVfMmtCaWI1VXVoaVF5c0lPaWtCX01EZmdqNmNIdkNOWXl5SzhORF9NQktRN2FDV01hUzF4Y1BES2MxZDlaZWRHeTN1bkNQWC1qb1JseE5xajZ3MkNwakpubG4tX29yS2djMG55aExJdmVxdW1zOXRDRVp3VFRCeU1oZUptc2RUUmt4a00tZw?oc=5" target="_blank">Computationally Designed Receptors Help Engineered T Cells Control Tumors</a>&nbsp;&nbsp;<font color="#6f6f6f">Genetic Engineering and Biotechnology News</font>
<a href="https://news.google.com/rss/articles/CBMiX0FVX3lxTFBYRVpqYzFVQzJIN0FMdjRCM25aSTJubnNNM3E1OWRPRWJpYVRiU0JKby16TERxNjlhMUI0cjdhZlY3YndCeUxDaU1oYTZJZGE2Y2s2SnUyYXotbFBZaTVR?oc=5" target="_blank">Tumour-specific bioorthogonal synthesis of proteolysis-targeting chimeras and nanoparticles boosts T cell activity</a>&nbsp;&nbsp;<font color="#6f6f6f">Nature</font>
<a href="https://news.google.com/rss/articles/CBMiX0FVX3lxTFA3eDhyWWh0bTFURTViRElkZENxR1R3d2xVcTBDMHNTUTgwN3ROMEFsSkloUnAzTEdkX3BaNFc0RTZCeHA3dE9lMG4ybW9TYmpGUUFVbllMNWgtWHZadHl3?oc=5" target="_blank">Engineering potent chimeric antigen receptor T cells by programming signaling during T-cell activation</a>&nbsp;&nbsp;<font color="#6f6f6f">Nature</font>
<a href="https://news.google.com/rss/articles/CBMiX0FVX3lxTE9BWGhYNTY1YjZLZVFxRmtieDlfQ0FMMTlSX2JTaDd6SjFpX0M3YnktRVNzQ2ZlTXBQeG1ha2dobmYwUHV0RnJqeXlXWTEzTk1DV3N0NVl0V20tMlRJX0ZJ?oc=5" target="_blank">Targeting inflammation with chimeric antigen receptor macrophages using a signal switch</a>&nbsp;&nbsp;<font color="#6f6f6f">Nature</font>
<a href="https://news.google.com/rss/articles/CBMiX0FVX3lxTE9aTXBSSExPQmtZSlVySnZKR0k2d1VpR3pheHpCU2t0ZjYxamQ2RW4zR2tDbU85SnZVSnhiQlBIQzdoemlkYkJ5SjA4ZHJfVGJhTEJITE1MZWwzZ0hIeHNZ?oc=5" target="_blank">Directed evolution-based discovery of ligands for in vivo restimulation of chimeric antigen receptor T cells</a>&nbsp;&nbsp;<font color="#6f6f6f">Nature</font>
<a href="https://news.google.com/rss/articles/CBMiX0FVX3lxTE4zaTFfQlBBMHpVMVIzb0xFdVlaTjdoNWJqcndiSmwzRFY1dkdnbTZUR29XSHh4Vjdwa05ETkVObVF5RGJWSnNqNHZjRFoydDhkeDItMVF0aDFNZDZrb2Rj?oc=5" target="_blank">Sequence and structural determinants of efficacious de novo chimaeric antigen receptors</a>&nbsp;&nbsp;<font color="#6f6f6f">Nature</font>
<a href="https://news.google.com/rss/articles/CBMiX0FVX3lxTE9Fbnp4VTZkY3F1bFdmVHJkU0Y4Q3FmYTQ5cXVRTG5KUDlKbDR1WkFhV2hISEE4ZXV0YXFzUjFUREdJbnlQSUloU093NGdnN01sT1NsaEdvSHRJRWhtck53?oc=5" target="_blank">Transitioning from native to synthetic receptors: broadening T-cell engineering and beyond</a>&nbsp;&nbsp;<font color="#6f6f6f">Nature</font>
<a href="https://news.google.com/rss/articles/CBMiWEFVX3lxTE9iVDZ1TlRoVzM0NXBic1E4bi10aDBtNkRVNlpMOWpkZ1dPdE4zc3AtRXM5VzRYVGk0bXd4aFZWcjc3QjdmRFJVMVBwSVNGaEMzTG1QcXVEbk8?oc=5" target="_blank">Immune cell engineering for cancer therapy 2026</a>&nbsp;&nbsp;<font color="#6f6f6f">Nature</font>
<a href="https://news.google.com/rss/articles/CBMiX0FVX3lxTE5JUnFjSC13SmdnSmlhM1NiTkIxMXFsS1BRNzF5akJPV1ZBV1B5Uk4yNmRCOTRJRUhhTmNEZ0RDZWl5WkFvQ1dqZm9Cd2UxQUFyVFJobG9tNHZnSXo5ZVA0?oc=5" target="_blank">Development of NK cell-based cancer immunotherapies through receptor engineering</a>&nbsp;&nbsp;<font color="#6f6f6f">Nature</font>
<a href="https://news.google.com/rss/articles/CBMiX0FVX3lxTE5SRTU1dTZ0Y25tUnJtVUxadTEwZjduNUZldXJWeGF2VUtGblNkbjVaU2tBOTFoRnBRbUdockVZVXAwaWZkZmRWU0FUT2p0Y1lteXY5SHMzRWExQzNkdVo4?oc=5" target="_blank">Solid tumour CAR-T cells engineered with fusion proteins targeting PD-L1 for localized IL-12 delivery</a>&nbsp;&nbsp;<font color="#6f6f6f">Nature</font>
<a href="https://news.google.com/rss/articles/CBMiX0FVX3lxTE1pODhmV2JjRFczbUhkejJaZy1CSmhSRERSa2VXa1BRRjYxTnJob01uR0o3TEYxenBaV1ZGdi1sRXctaVNvN243bzN5eFFBbGM3bnRua0VkRXBaUjRxMTBF?oc=5" target="_blank">Chimeric antigen receptor macrophages (CAR-M) sensitize HER2+ solid tumors to PD1 blockade in pre-clinical models</a>&nbsp;&nbsp;<font color="#6f6f6f">Nature</font>
<a href="https://news.google.com/rss/articles/CBMiX0FVX3lxTFBMZ0F5alBkNmJub0I5TE5fZF9iSl9QMjlWcmxCSktuM2o2Z2JmMVNXMjZhNHBBOHdDWXp1ak1oREkzejV3aDRoMDhHY2FCTkJZS1JQWU1hVVRrZ1h1SnB3?oc=5" target="_blank">Universal redirection of CAR T cells against solid tumours via membrane-inserted ligands for the CAR</a>&nbsp;&nbsp;<font color="#6f6f6f">Nature</font>
<a href="https://news.google.com/rss/articles/CBMiX0FVX3lxTFBxVy1tTWdReEtOeExuV3B1LUc3V29YZVVZZWQ1dUZxclpMWGFFQ0FOLU1hcF93UUdJVk5hb09ieGVscWgweG9iSkRjdHExeFNGWGtuRmV6c1VpZFZCRDg0?oc=5" target="_blank">Chimeric antigen receptor-based natural killer cell immunotherapy in cancer: from bench to bedside</a>&nbsp;&nbsp;<font color="#6f6f6f">Nature</font>
<a href="https://news.google.com/rss/articles/CBMiYEFVX3lxTE9EMzFqM011Zjllb1NfR1BmU2FobmVNVndWMlRYSXdmaGs1YUNHQjJjMWxObkNPYzJkWmRYVHdidVhpWGlsV3gxX0M4dm1YMnBRTVRvUEwtYU9zVGhPX3NkQg?oc=5" target="_blank">In vivo CAR T cell generation to treat cancer and autoimmune disease</a>&nbsp;&nbsp;<font color="#6f6f6f">Science | AAAS</font>
<a href="https://news.google.com/rss/articles/CBMiX0FVX3lxTE9qRHZtZDVlcDJzYkUzVWZMYXE1dFFRYUllb2NyLUxvS1U5enFwOHZncU52OTZ2a0NIYWpyRkExTTVPdXJWaW5kX2h3eEQxMFZhR2VnWVVtRFBRNlJTSC1R?oc=5" target="_blank">Engineering of CD8+ T cells with an HIV-specific synthetic notch receptor to secrete broadly therapeutic antibodies for combining antiviral humoral and cellular immune responses | mBio</a>&nbsp;&nbsp;<font color="#6f6f6f">ASM Journals</font>
<a href="https://news.google.com/rss/articles/CBMikgFBVV95cUxQSW10dHRsTDZUQXJoTkNyUW9MWnMtTGJ3ZTVhLUNodWlmdEt4NWd3ZVZNRzJBTEdjSkFKTUxRWDVvalJZdlJmNFBWNlEwVXJUODlUZjFwbVZNNkVnVHZPRVN0V0tYYlVET0FoNUpBNjVSNkJKUzBXS2NJSS1kekRGS3JWZzJ0RGFNeFB1elVRMmdLZw?oc=5" target="_blank">Current strategies for armoring chimeric antigen receptor T-cells to overcome barriers of the solid tumor microenvironment</a>&nbsp;&nbsp;<font color="#6f6f6f">Frontiers</font>
<a href="https://news.google.com/rss/articles/CBMiX0FVX3lxTE1xX3llQTR3REFNQW5mZnlEMGRySU1rX3JOcVJ0U0FlQUk4OTRqUlNOV3FaRk05RnBVN1o1TnhUVlNWSmc1S29IZFNmWmdSbHFLc0dEUjBwSVJ3Z3dxekNn?oc=5" target="_blank">signalling through dual receptor knockout in CAR T cells enhances therapeutic efficacy in solid tumours</a>&nbsp;&nbsp;<font color="#6f6f6f">Nature</font>
<a href="https://news.google.com/rss/articles/CBMiX0FVX3lxTFBlV3pDc29lcWRVQ3NNSjVqc3N0N1JTbzYtMVZJNlNvUFYwR3piVDRkV0pjRVo5WS16aVhwUFJ6eERVX1p4cmpVaVJRQ29ob01kUHdqUm5PcS1uTU9uZ1pV?oc=5" target="_blank">CAR-macrophages in solid tumors: promise, progress, and prospects</a>&nbsp;&nbsp;<font color="#6f6f6f">Nature</font>
<a href="https://news.google.com/rss/articles/CBMisAFBVV95cUxOMDZnMWhDZlhvM2ZsTjZVMUV5ZWFwS2Q1SS1KVGY0TEJoMTg0NlJtdFk2YWlPQmYtSVpVcHpuQXlhVm1pUGNzNmVBa0FHM0RGeGtVYm9TcHZuRU8wdTBYb3RhWWh6MFhBVVNrOEc2ZkRmTWJBck9nNzVJQUNudDg2RFpxUGxXYnFOMmg5cDFzSHVwQkdKMjlYZmlRN3k5WWFjUmdvcms5R0RFdWtoNzhMbA?oc=5" target="_blank">Engineering CAR T Cells to Target the HIV Reservoir</a>&nbsp;&nbsp;<font color="#6f6f6f">Frontiers</font>
<a href="https://news.google.com/rss/articles/CBMikgFBVV95cUxPUVVKSTEwY2FWb3NQdWhtN1BkdGpKYTJZTVZ4cUxHM1dsOEYweXJKNmlLTk1fWkNDeUhDWEtmUzlKSkZoUjZTSmdoRWwzRUtfeE5wN0doYVlNeXZZcGNNNFE2MUw5N2laeThwcUhJN2dIVmxnODJZajdYalNwR1VGT2RtNTRJTzBGcXN0d0gxeHA4QQ?oc=5" target="_blank">Chimeric antigen receptor T-cell therapy in autoimmune diseases</a>&nbsp;&nbsp;<font color="#6f6f6f">Frontiers</font>
<a href="https://news.google.com/rss/articles/CBMiX0FVX3lxTE5IbWlVemJscWU0VC1WS2ZDYkFUX2NSMVpOX25oOHplUlYtUGMzR005NE1ZeUUyblFMeFl5VkpRNzdCcVBWalNrN0dTNmIzbGNvbkpnR0xybklwUGZ5a0Vj?oc=5" target="_blank">Chimeric deubiquitinase engineering reveals structural basis for specific inhibition of the mitophagy regulator USP30</a>&nbsp;&nbsp;<font color="#6f6f6f">Nature</font>